Daniel Rudeklint
Vorstandsvorsitzender bei EMOTRA AB (PUBL)
Profil
Mr. Daniel Rudeklint, CPA, is a President, Chief Executive Officer, CFO & Director at Emotra AB and a Chief Financial Officer & Director at Peptonic Medical AB.
He is on the Board of Directors at KebNi AB, Emotra AB and Peptonic Medical AB.
He received his graduate degree from Luleå University of Technology.
Aktive Positionen von Daniel Rudeklint
| Unternehmen | Position | Beginn |
|---|---|---|
| EMOTRA AB (PUBL) | Vorstandsvorsitzender | 01.11.2021 |
| PEPTONIC MEDICAL AB | Finanzdirektor/CFO | 15.05.2024 |
| KEBNI AB | Direktor/Vorstandsmitglied | 01.06.2022 |
Ausbildung von Daniel Rudeklint
| Luleå University of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PEPTONIC MEDICAL AB | Health Technology |
| KEBNI AB | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
Emotra AB
 Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
